Hosted on MSN1mon
FDA says tirzepatide shortage is over after taking a second look
The FDA initially declared the tirzepatide shortage over in October, but the Outsourcing Facilities Association, a trade group for compounding pharmacists, sued, claiming the drug was still in ...
Pharma giant seeks to join lawsuit against FDA over weight loss drugs
Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by ...
BofA retains Hims & Hers stock rating amid pharma challenges
BofA Securities maintained an Underperform rating on shares of Hims & Hers Health, Inc. (NYSE:HIMS) with a steady price ...
Benzinga.com18d
3LLY : Eli Lilly Joins FDA Lawsuit Over Compounded Obesity Drugs, Seeks
Get 5 New Stock Recommendations Every Week As expected by many, Eli Lilly And Co LLY filed a motion to intervene as a defendant in a case between the Outsourcing Facilities Association and ...
FDA Says Shortage of GLP-1 Tirzepatide Is Over
THURSDAY, Dec. 19, 2024 (HealthDay News) -- The U.S. Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the diabetes/weight-loss medication ...
Becker's Hospital Review13d
Novo Nordisk joins Eli Lilly in legal challenge over GLP-1 compounding
The move intensifies an ongoing legal battle, as Novo Nordisk joins its major competitor Eli Lilly in opposing a recent initiative by the Outsourcing Facilities Association to include liraglutide in ...
Building Strong Outsourcing Partnerships To Deal With A Challenging Economy
Strategic outsourcing can be a bulwark for companies, helping to guard against the full effects of a challenging economy.
Yahoo Finance19d
Eli Lilly Joins FDA Lawsuit Over Compounded Obesity Drugs, Seeks 'Swift End' And 'To Protect Its Interests'
As expected by many, Eli Lilly And Co (NYSE:LLY) filed a motion to intervene as a defendant in a case between the Outsourcing Facilities Association and FarmaKeio Custom Compounding against the FDA.
Reuters20d
Lilly asks to join lawsuit over compounded versions of its weight-loss drugs
The FDA declined to comment. The Outsourcing Facilities Association, which brought the lawsuit along with a Texas compounding pharmacy did not immediately respond to requests for comment.
Novo Nordisk Pushes FDA To Exclude Compounding For Its Early-Generation Diabetes Drug
Danish pharmaceutical giant Novo Nordisk A/S (NYSE:NVO) submitted a Citizen Petition to the FDA requesting the exclusion of ...
Yahoo Finance1mon
FDA confirms end of Eli Lilly’s tirzepatide shortage after re-evaluation
The FDA declared the tirzepatide shortage over in October 2023, but a lawsuit by Outsourcing Facilities Association, a trade group for compounding pharmacists, pushed the FDA to reconsider.
Seeking Alpha18d
Novo Nordisk seeks to block compounded Victoza
In a Citizen Petition posted on Regulations.gov, Novo Nordisk (NVO) noted that the Outsourcing Facilities Association, or OFA, has nominated liraglutide be added to their list of bulk drug ...